Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Report ID | 236880 |
Drug Identification Number | 02402068 |
Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Common or Proper name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | TAZOBACTAM PIPERACILLIN |
Strength(s) | 0.25G 2G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | ml |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2024-09-05 |
Estimated end date | Unknown |
Actual end date | 2025-02-18 |
Shortage status | Resolved |
Updated date | 2025-02-19 |
Company comments | PIPERACILLIN AND TAZOBACTAM FOR INJECTION will be avaible under Eugia label : 02528673 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2025-02-19 | French | Compare |
v4 | 2025-02-19 | English | Compare |
v3 | 2024-09-06 | English | Compare |
v2 | 2024-09-05 | French | Compare |
v1 | 2024-09-05 | English | Compare |
Showing 1 to 5 of 5